CONTRIBUIÇÕES DA NEUROCIÊNCIA NA COMPREENSÃO DOS TRANSTORNOS DE APRENDIZAGEM
International Integralize Scientific · 27.02.2026 · 6 (56)
DOI: 10.63391/cp3j6w46 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Integralize Scientific, online erschienen am 27.02.2026. Verfasst von Nayrlane Dutra. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The work highlights the procedural analysis of the dialogue between neuroscience discoveries and learning disabilities regarding the understanding of their neurobiological foundations. The learning process causes changes in cognitive structure due to information processing; neuroscience demonstrates this cognitive change through studies of brain function. To define the characteristics of learning disorders, it is necessary to differentiate them from learning difficulties, which, according to studies, can be caused by extrinsic, pedagogical, or social factors. Learning disorders (dyslexia and dyscalculia) are neurobiological in origin, characterized by conditions in which there is a deficit in neurological development observed from the early stages of development, impacting the learning process. Symptoms appear before literacy acquisition and are diagnosed in elementary school. Assessment by a multidisciplinary team is essential for an accurate diagnosis and identification of deficit skills, allowing for assertive intervention.
Zitieren
APA
Dutra, N. (2026). CONTRIBUIÇÕES DA NEUROCIÊNCIA NA COMPREENSÃO DOS TRANSTORNOS DE APRENDIZAGEM. International Integralize Scientific, 6(56). https://doi.org/10.63391/cp3j6w46
Vancouver
Dutra N. CONTRIBUIÇÕES DA NEUROCIÊNCIA NA COMPREENSÃO DOS TRANSTORNOS DE APRENDIZAGEM. International Integralize Scientific. 2026;6(56). doi:10.63391/cp3j6w46
BibTeX
@article{Dutra2026,
author = {Dutra, Nayrlane},
title = {CONTRIBUIÇÕES DA NEUROCIÊNCIA NA COMPREENSÃO DOS TRANSTORNOS DE APRENDIZAGEM},
journal = {International Integralize Scientific},
year = {2026},
volume = {6},
number = {56},
doi = {10.63391/cp3j6w46}
}
EUVIMED